Condition
H.Pylori
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07211880Not ApplicableCompletedPrimary
Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study
NCT06275204Recruiting
H. Pylori Screen-and-treat Study in a Population of Young Adults
NCT02063932Unknown
Association Between Confocal Laser Endomicroscopic (CLE) Features and Gastric Mucosal Microbiome
NCT01667692Phase 4Completed
Aizthromycin or Clarithromycin in H-pylori Eradication Regimen
Showing all 4 trials